← ORTHOPEDIATRICS CORP
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $37.3m |
$45.6m
+22.31%
|
$57.6m
+26.17%
|
$72.6m
+26.05%
|
$71.1m
-2.03%
|
$98.0m
+37.95%
|
$122.3m
+24.72%
|
$148.7m
+21.62%
|
$204.7m
+37.65%
|
$236.3m
+15.45%
|
$252.7m
+6.93%
|
|
| Cost of Revenue | $10.9m |
$11.2m
+2.19%
|
$14.9m
+33.21%
|
$17.9m
+20.53%
|
$16.0m
-10.52%
|
$24.6m
+53.59%
|
$31.6m
+28.33%
|
$37.5m
+18.50%
|
$56.1m
+49.76%
|
$63.7m
+13.47%
|
$66.6m
+4.56%
|
|
| Gross Profit | $26.4m |
$34.5m
+30.66%
|
$42.7m
+23.89%
|
$54.6m
+27.97%
|
$55.0m
+0.75%
|
$73.4m
+33.38%
|
$90.7m
+23.51%
|
$111.3m
+22.71%
|
$148.6m
+33.57%
|
$172.7m
+16.19%
|
$186.1m
+7.80%
|
|
| Interest Income (Expense), Net | — | — | — | — | — | ($2.2m) |
($2.4m)
-7.88%
|
$198k
+108.17%
|
$2.6m
+1223.74%
|
$6.0m
+128.77%
|
— | |
| Research and Development Expense | $2.2m | $3.4m | $4.7m | $5.7m | $5.3m | $5.5m | $8.0m | $10.2m | $11.0m | $9.1m | $9.1m | |
| Selling and Marketing Expense | $16.7m | $20.5m | $26.6m | $31.3m | $31.9m | $39.7m | $45.1m | $51.4m | $64.3m | $72.7m | $199.8m | |
| General and Administrative Expense | $11.6m | $17.0m | $20.9m | $26.7m | $38.3m | $46.1m | $59.4m | $75.4m | $102.8m | $119.8m | $122.9m | |
| Amortization of Intangible Assets | $35k | $246k | $378k | $887k | $3.2m | $4.5m | $6.0m | $7.1m | $7.8m | $8.2m | — | |
| Operating Expenses | $32.5m | $40.9m | $52.2m | $63.7m | $81.8m | $91.4m | $116.1m | $138.0m | $183.6m | $211.9m | $208.9m | |
| Operating Income (Loss) | ($6.1m) |
($6.5m)
-5.63%
|
($9.6m)
-47.61%
|
($9.1m)
+4.98%
|
($26.8m)
-194.76%
|
($18.0m)
+32.63%
|
($25.4m)
-40.92%
|
($26.8m)
-5.32%
|
($35.0m)
-30.87%
|
($39.2m)
-12.08%
|
($22.8m)
+41.96%
|
|
| Interest Expense | $1.5m | $2.5m | $2.3m | $3.5m | $3.4m | — | — | — | — | — | $6.0m | |
| Interest Expense, Debt | — | — | — | — | — | — | — | $42k | $35k | $27k | $6.0m | |
| Other Nonoperating Income (Expense) | $1.0m | $30k | ($217k) | ($70k) | $20k | $1.1m | ($1.8m) | $2.3m | ($1.1m) | $6.0m | — | |
| Interest Expense (non-operating) | — | — | — | — | — | — | — | — | $2.6m | $6.0m | $6.0m | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | — | — | — | ($12.0m) | ($28.8m) | ($9.2m) | $6.5m | ($12.6m) | ($27.3m) | ($37.1m) | ($39.4m) | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | — | — | — | $12.7m | $33.7m | ($17.4m) | ($3.7m) | ($21.3m) | ($41.9m) | ($39.2m) | ($39.4m) | |
| Current Income Tax Expense (Benefit) | — | — | $0 | $0 | $723k | $1.1m | $85k | $825k | $629k | $613k | $278k | |
| Income Tax Expense (Benefit) | $0 | $0 | $0 | $0 | ($723k) | ($1.1m) | ($4.9m) | ($338k) | ($4.1m) | $460k | $278k | |
| Net Income (Loss) Attributable to Parent | ($6.6m) |
($8.9m)
-35.91%
|
($12.0m)
-34.63%
|
($13.7m)
-14.19%
|
($32.9m)
-139.92%
|
($16.3m)
+50.64%
|
$1.3m
+107.74%
|
($21.0m)
-1767.25%
|
($37.8m)
-80.33%
|
($39.6m)
-4.83%
|
($39.7m)
-0.20%
|
|
| Net Income (Loss) Available to Common Stockholders, Basic | ($12.4m) |
($23.5m)
-89.03%
|
($12.0m)
+48.90%
|
($13.7m)
-14.19%
|
($32.9m)
-139.92%
|
— | $1.2m |
($21.0m)
-1798.30%
|
($37.8m)
-80.33%
|
($39.6m)
-4.83%
|
($39.7m)
-0.20%
|
|
| Earnings Per Share, Basic | ($7.14) | ($5.86) | ($0.96) | ($0.94) | ($1.82) | ($0.84) | $0.06 | ($0.92) | ($1.64) | ($1.69) | ($1.68) | |
| Earnings Per Share, Diluted | ($7.14) | ($5.86) | ($0.96) | ($0.94) | ($1.82) | ($0.84) | $0.06 | ($0.92) | ($1.64) | ($1.69) | ($1.68) | |
| Income (Loss) from Continuing Operations, Per Basic Share | ($7.14) | ($5.86) | ($0.96) | ($1) | ($2) | ($1) | $0 | ($1) | ($2) | ($2) | — | |
| Income (Loss) from Continuing Operations, Per Diluted Share | ($7.14) | ($5.86) | ($0.96) | ($1) | ($2) | ($1) | $0 | ($1) | ($2) | ($2) | — | |
| Weighted Average Number of Shares Outstanding, Basic | — | — | — | — | — | 19.3m | 20.7m | 22.7m | 23.1m | 23.5m | 23.7m | |
| Weighted Average Number of Shares Outstanding, Diluted | — | — | — | — | — | 19.3m | 20.9m | 22.7m | 23.1m | 23.5m | 23.7m | |
| Additional Financial Items | ||||||||||||
| Business Combination, Acquisition Related Costs | — | — | — | $737k | — | — | — | — | — | — | — | |
| Goodwill, Impairment Loss | — | — | — | — | — | — | $0 | $0 | $0 | $1.9m | $4.6m | |
| Realized Investment Gains (Losses) | — | — | — | — | — | — | ($1.6m) | ($1.4m) | $119k | $32k | — | |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | ($6.6m) | ($8.9m) | ($12.0m) | ($12.7m) | ($32.9m) | ($16.3m) | $1.3m | ($21.0m) | ($37.8m) | ($39.6m) | — | |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | — | — | — | — | — | ($16.3m) | — | — | — | — | — | |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent | $0 | $0 | — | ($1.0m) | $0 | $0 | — | — | — | — | — |